UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 112

Sortiert nach

Second-Line Oxaliplatin, Folinic Acid, and Fluorouracil Versus Folinic Acid and Fluorouracil Alone for Gemcitabine-Refractory Pancreatic Cancer: Outcomes From the CONKO-003 Trial

Journal of clinical oncology, 2014-08, Vol.32 (23), p.2423-2429

2014

Link zum Volltext

Verfügbarkeit prüfen

Mucin-1 Protein Is a Prognostic Marker for Pancreatic Ductal Adenocarcinoma: Results From the CONKO-001 Study

Frontiers in oncology, 2021-07, Vol.11, p.670396-670396

2021

Link zum Volltext

Verfügbarkeit prüfen

Post-Vaccination Anti-SARS-CoV-2-Antibody Response in Patients with Multiple Myeloma Correlates with Low CD19+ B-Lymphocyte Count and Anti-CD38 Treatment

Cancers, 2021-07, Vol.13 (15), p.3800

2021

Link zum Volltext

Verfügbarkeit prüfen

Effects of Exercise Training on Patient-Specific Outcomes in Pancreatic Cancer Patients: A Scoping Review

Cancers, 2023-12, Vol.15 (24), p.5899

2023

Link zum Volltext

Verfügbarkeit prüfen

Dose-escalated radiotherapy for unresectable or locally recurrent pancreatic cancer: Dose volume analysis, toxicity and outcome of 28 consecutive patients

PloS one, 2017-10, Vol.12 (10), p.e0186341

2017

Link zum Volltext

Verfügbarkeit prüfen

Completion of FLOT Therapy, Regardless of Tumor Regression, Significantly Improves Overall Survival in Patients with Esophageal Adenocarcinoma

Cancers, 2022-02, Vol.14 (4), p.1084

2022

Link zum Volltext

Verfügbarkeit prüfen

Characterization of RARRES1 Expression on Circulating Tumor Cells as Unfavorable Prognostic Marker in Resected Pancreatic Ductal Adenocarcinoma Patients

Cancers, 2022-09, Vol.14 (18), p.4405

2022

Link zum Volltext

Verfügbarkeit prüfen

Risk estimation for biliary tract cancer: Development and validation of a prognostic score

Liver international, 2017-12, Vol.37 (12), p.1852-1860

2017

Link zum Volltext

Verfügbarkeit prüfen

Tumor-Stroma Interaction in PDAC as a New Approach for Liquid Biopsy and its Potential Clinical Implications

Frontiers in cell and developmental biology, 2022-05, Vol.10, p.918795-918795

2022

Link zum Volltext

Verfügbarkeit prüfen

Circulating Cancer Associated Macrophage-like Cells as a Potential New Prognostic Marker in Pancreatic Ductal Adenocarcinoma

Biomedicines, 2022-11, Vol.10 (11), p.2955

2022

Link zum Volltext

Verfügbarkeit prüfen

Lymphocytopenia and Anti-CD38 Directed Treatment Impact the Serological SARS-CoV-2 Response after Prime Boost Vaccination in Patients with Multiple Myeloma

Journal of clinical medicine, 2021-11, Vol.10 (23), p.5499

2021

Link zum Volltext

Verfügbarkeit prüfen

Dual Targeting of the EGFR/HER2 Pathway in Combination with Systemic Chemotherapy in Refractory Pancreatic Cancer—The CONKO-008 Phase I Investigation

Journal of clinical medicine, 2022-08, Vol.11 (16), p.4905

2022

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of CAP7.1 as Second-Line Treatment for Advanced Biliary Tract Cancers: Data from a Randomised Phase II Study

Cancers, 2020-10, Vol.12 (11), p.3149

2020

Link zum Volltext

Verfügbarkeit prüfen

Differenzialtherapie bei fortgeschrittenen Gallengangskarzinomen

Gastro-News, 2022-02, Vol.9 (1), p.45-49

2022

Link zum Volltext

Verfügbarkeit prüfen

Differenzialtherapie bei fortgeschrittenen Gallengangskarzinomen

InFo Hämatologie + Onkologie, 2021-09, Vol.24 (9), p.21-26

2021

Link zum Volltext

Verfügbarkeit prüfen

Perioperative treatment options in resectable pancreatic cancer- how to improve long-term survival

World journal of gastrointestinal oncology, 2016-03, Vol.8 (3), p.248-257

2016

Link zum Volltext

Verfügbarkeit prüfen

Primary prevention and treatment of venous thromboembolic events in patients with gastrointestinal cancers- Review

World journal of gastrointestinal oncology, 2016-03, Vol.8 (3), p.258-270

2016

Link zum Volltext

Verfügbarkeit prüfen

An inflammatory subtype of pancreatic ductal adenocarcinoma is associated with poor prognosis and increased perioperative mortality

Journal of pancreatology (Online), 2019-09, Vol.2 (3), p.107-112

2019

Link zum Volltext

Verfügbarkeit prüfen

Two patients with rare mixed adenoneuroendocrine carcinomas of the rectum

SAGE open medical case reports, 2018, Vol.6, p.2050313X18758816

2018

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer

The New England journal of medicine, 2021-04, Vol.384 (13), p.1191-1203

2021

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trial

JAMA : the journal of the American Medical Association, 2013-10, Vol.310 (14), p.1473

2013

Link zum Volltext

Verfügbarkeit prüfen

CONKO-005: Adjuvant Chemotherapy With Gemcitabine Plus Erlotinib Versus Gemcitabine Alone in Patients After R0 Resection of Pancreatic Cancer: A Multicenter Randomized Phase III Trial

Journal of clinical oncology, 2017-10, Vol.35 (29), p.3330-3337

2017

Link zum Volltext

Verfügbarkeit prüfen

Peritoneales Mesotheliom und Pseudomyxoma peritonei

Best practice onkologie, 2024-02, Vol.19 (1-2), p.8-25

2024

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of Rivaroxaban in Patients with CAT: A Pooled Meta-Analysis of 3 Randomized Controlled Trials

Blood, 2021-11, Vol.138 (Supplement 1), p.1068-1068

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 112

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(101)
Mit Volltextzugriff
(104)

Publikationsform

Sprache

Englisch
(101)
Deutsch
(11)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

Science & Technology
(61)
Life Sciences & Biomedicine
(57)
Oncology
(43)
Humans
(42)
Female
(30)
Male
(27)
Middle Aged
(26)
Pancreatic Cancer
(26)
Aged
(25)
Patients
(22)
Chemotherapy
(21)
Adult
(17)
Prognosis
(16)
Cancer
(14)
Pancreatic Neoplasms - Pathology
(14)
Aged, 80 And Over
(13)
Pancreatic Neoplasms - Drug Therapy
(13)
Tumors
(13)
Cancer Therapies
(12)
Deoxycytidine - Analogs & Derivatives
(11)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Second-Line Oxaliplatin, Folinic Acid, and Fluorouracil Versus Folinic Acid and Fluorouracil Alone for Gemcitabine-Refractory Pancreatic Cancer: Outcomes From the CONKO-003 Trial

Hematopoietic lineage distribution and evolutionary dynamics of clonal hematopoiesis

Mucin-1 Protein Is a Prognostic Marker for Pancreatic Ductal Adenocarcinoma: Results From the CONKO-001 Study

Post-Vaccination Anti-SARS-CoV-2-Antibody Response in Patients with Multiple Myeloma Correlates with Low CD19+ B-Lymphocyte Count and Anti-CD38 Treatment

Effects of Exercise Training on Patient-Specific Outcomes in Pancreatic Cancer Patients: A Scoping Review

Dose-escalated radiotherapy for unresectable or locally recurrent pancreatic cancer: Dose volume analysis, toxicity and outcome of 28 consecutive patients

Completion of FLOT Therapy, Regardless of Tumor Regression, Significantly Improves Overall Survival in Patients with Esophageal Adenocarcinoma

Characterization of RARRES1 Expression on Circulating Tumor Cells as Unfavorable Prognostic Marker in Resected Pancreatic Ductal Adenocarcinoma Patients

Risk estimation for biliary tract cancer: Development and validation of a prognostic score

Tumor-Stroma Interaction in PDAC as a New Approach for Liquid Biopsy and its Potential Clinical Implications

Circulating Cancer Associated Macrophage-like Cells as a Potential New Prognostic Marker in Pancreatic Ductal Adenocarcinoma

Lymphocytopenia and Anti-CD38 Directed Treatment Impact the Serological SARS-CoV-2 Response after Prime Boost Vaccination in Patients with Multiple Myeloma

Dual Targeting of the EGFR/HER2 Pathway in Combination with Systemic Chemotherapy in Refractory Pancreatic Cancer—The CONKO-008 Phase I Investigation

Efficacy and Safety of CAP7.1 as Second-Line Treatment for Advanced Biliary Tract Cancers: Data from a Randomised Phase II Study

Differenzialtherapie bei fortgeschrittenen Gallengangskarzinomen

Differenzialtherapie bei fortgeschrittenen Gallengangskarzinomen

Perioperative treatment options in resectable pancreatic cancer- how to improve long-term survival

Primary prevention and treatment of venous thromboembolic events in patients with gastrointestinal cancers- Review

An inflammatory subtype of pancreatic ductal adenocarcinoma is associated with poor prognosis and increased perioperative mortality

Two patients with rare mixed adenoneuroendocrine carcinomas of the rectum

Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer

Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trial

CONKO-005: Adjuvant Chemotherapy With Gemcitabine Plus Erlotinib Versus Gemcitabine Alone in Patients After R0 Resection of Pancreatic Cancer: A Multicenter Randomized Phase III Trial

Peritoneales Mesotheliom und Pseudomyxoma peritonei

Efficacy and Safety of Rivaroxaban in Patients with CAT: A Pooled Meta-Analysis of 3 Randomized Controlled Trials

Suchergebnisse filtern